Decision: Favourable

Study Title:

Protocol IM026024: A Phase 2, Multicenter, Randomized, Double-blind, PlaceboControlled, Study to Evaluate the Efficacy and Safety of BMS-986256 in Participants with Active Systemic Lupus Erythematosus

  • NREC Code:

    21-NREC-CT-127

  • Decision:

    Favourable

  • Meeting Date:

    03/11/2021

  • Study Type:

    CT application

  • Principal Investigator:

    Dr Trevor Duffy

  • PI Institution:

    Connolly Hospital

  • Sponsor:

    Bristol Myers Squibb International Corporation

Scroll to Top